DHR vs INTS
Danaher Corporation (DHR) versus Intensity Therapeutics, Inc. Common stock (INTS) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
INTS does not have a complete income-statement cache yet.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. INTS currently screens at market cap $7.7M.
Not investment advice. Open the DHR and INTS stock pages for the full models.
Not investment advice.